Show Summary Details
Page of

Chronic leukaemias 

Chronic leukaemias
Chronic leukaemias

Hemant Malhotra

, Lalit Kumar

, Pankaj Malhotra

, Devendra Hiwase

, and Ravi Bhatia

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 13 July 2020

Chronic Leukaemia, as contrasted to the acute luekemia, are slowly growing clonal malignancies of the hematopoietic system in which, even without active intervention, survival is possible for several years. In the past decade there have been several advances in the basic understanding of these diseases which have lead to improvement in survival of several decades in the majority of patients which is now being referred to as ‘operational cure’. This chapter covers the chronic leukaemias (chronic myeloid leukaemia (CML), chronic lymphocytic leukaemia (CLL), hairy cell leukaemia, prolymphocytic leukaemia, large granular lymphocytic leukaemia (LGL), and hairy cell leukaemia variant (HCL-v), including epidemiology, staging and diagnosis, molecular biology, pathology, medical management, disease monitoring, management of relapse/refraction, and future directions.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.